- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 11.10. | Merck and Astellas/Pfizer's bladder cancer combination receives MHRA approval | ||
| 11.10. | Eli Lilly and insitro collaborate to advance new treatments for metabolic diseases | ||
| 10.10. | Astellas and AviadoBio enter exclusive dementia gene therapy deal worth over $2bn | ||
| 10.10. | Merck's Keytruda shows promise as perioperative head and neck cancer treatment | ||
| 10.10. | GSK's RSV vaccine Arexvy shown to protect older adults across three seasons | ||
| 10.10. | PM Society Awards 2025 open for entries | ||
| 09.10. | Merck and Mestag enter inflammatory disease partnership worth up to $1.9bn | ||
| 09.10. | Ipsen's Iqirvo approved by MHRA to treat primary biliary cholangitis in adults | ||
| 09.10. | PMLiVE's T40 - results announced! | ||
| 08.10. | AstraZeneca/Avillion share positive phase 3 results for asthma rescue treatment Airsupra | ||
| 08.10. | J&J's Erleada shows overall survival benefit in head-to-head prostate cancer study | ||
| 08.10. | ICR researchers reveal benefits of personalised radiotherapy for bladder cancer patients | ||
| 07.10. | AstraZeneca gains rights to CSPC's lipid-lowering therapy in deal worth over $1.9bn | ||
| 07.10. | AbbVie shares promising late-stage results for Parkinson's disease candidate tavapadon | ||
| 07.10. | ABPI highlights importance of NHS-industry partnerships in improving patient outcomes | ||
| 04.10. | Bristol Myers Squibb's Opdivo regimen granted FDA approval in NSCLC | ||
| 04.10. | Chiesi Group invests €400m to establish biotech centre of excellence in Italy | ||
| 04.10. | Researchers develop new approach to target cells affected by motor neurone disease | ||
| 03.10. | Eli Lilly announces new $4.5bn US site for manufacturing and drug development | ||
| 03.10. | GSK receives CHMP recommendation for meningococcal disease vaccine Menveo | ||
| 03.10. | NHS England begins newborn screening programme to identify rare genetic conditions | ||
| 03.10. | Results from Global Pharmaceutical Customer Experience survey | ||
| 03.10. | How patients are transforming cancer care: insights from ESMO on patient-centric oncology | ||
| 03.10. | Stats without stories: why journalists aren't covering your data | ||
| 02.10. | Sanofi/Regeneron's Dupixent approved by FDA to treat uncontrolled COPD |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
